QA: Aadi Bioscience Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001422142_2023_Aadi_Bioscience_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001422142, Aadi Bioscience Inc.

  xvar xval
0 AssetsCurrent 180,029,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 508,000
3 remainder_Assets 3,700,000
4 LiabilitiesCurrent 18,835,000
5 LiabilitiesNoncurrent 1,267,000
6 remainder_Liabilities 5,757,000
7 CostOfGoodsAndServicesSold 1,335,000
8 SellingGeneralAndAdministrativeExpense 40,176,000
9 ResearchAndDevelopmentExpense 32,662,000
10 remainder_Expenses 3,724,000
11 remainder_Revenues 15,216,000
12 remainder_NetIncome 2,168,000
13 remainder_ComprehensiveNetIncome -115,000
  yvar yval
0 Assets 184,237,000
1 Liabilities 25,859,000
2 Expenses 77,897,000
3 Revenues 15,216,000
4 StockholdersEquity 158,378,000
5 NetIncome -60,513,000
6 ComprehensiveNetIncome -60,570,500
7 BaseVar 152,746,000
8 EconomicCapitalRatio 2.02

Edgar->Model Mapping

Feature Distribution

Change over Time